Thrombosis associated with the use of recombinant activated factor VII: profiling two events.
Ng
Heng Joo
HJ
Department of Haematology, Singapore General Hospital, Outram Road, Singapore 169608, Republic of Singapore. ghenhj@sgh.com.sg
Loh
S M
SM
Tan
Daryl C L
DC
Lee
Lai Heng
LH
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001777:Blood Coagulation; D005169:Factor VIII / Q000037:antagonists & inhibitors; D015942:Factor VIIa / Q000009:adverse effects*; D006467:Hemophilia A / Q000188:drug therapy; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D011516:Prothrombin / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000009:adverse effects*; D012306:Risk; D013927:Thrombosis / Q000139:chemically induced*; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D020246:Venous Thrombosis / Q000139:chemically induced
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D011994:Recombinant Proteins; D011516:Prothrombin; D005169:Factor VIII; D015942:Factor VIIa